ELVN
Enliven Therapeutics Inc.
$20.92
+$0.09(+0.46%)
62
Overall
60
Value
90
Tech
36
Quality
Market Cap
$1.12B
Volume
312.77K
52W Range
$13.30 - $30.03
Target Price
$41.25
EPS Estimates Overview
| Current Quarter | $-0.43 | Next Quarter | $-0.47 |
| Current Year | $-1.95 | Next Year | $-2.19 |
| QoQ Growth | -9.3% | YoY Growth | -12.3% |
| 3Y EPS CAGR | N/A | Target Price | $41.25 |
| Consensus | Buy | Upside | +97.2% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $20.92 | +0.5% | 312.77K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW